Le Lézard
Classified in: Health
Subjects: MAV, FVT, CFG, MAT

Notice to the Media - Government of Canada to comment on the passage of Bill C-45


OTTAWA, June 19, 2018 /CNW/ - The Honourable Ginette Petitpas Taylor, Minister of Health, the Honourable Jody Wilson-Raybould, Minister of Justice and Attorney General of Canada, along with Parliamentary Secretary Bill Blair, will be available to media to comment on the passage of Bill C-45 in the Senate.

Date
June 20, 2018

Time
9:30 a.m. (EDT)

Location
Foyer
House of Commons, Parliament Hill
Ottawa, ON

 

SOURCE Health Canada


These press releases may also interest you

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...

at 16:42
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...



News published on and distributed by: